
Thorium Norway AS - Share Issue and Company Update
January 2025
Shareholders' Meeting and Business Update
Following the shareholders' meeting held on December 19th, 2024, Thorium Norway AS's Board of Directors presented the company's developments throughout 2024 and outlined plans for 2025-2026. The company has made significant progress in its thorium purification technology and development of applications within medical isotopes and nuclear fuel.
Share Issue Details
The Board has approved a share issue to secure working capital for continued development:
- Target raise: NOK 24.5 million
- Subscription price: NOK 25 per share
- Minimum subscription (new investors): NOK 1 million
- Existing shareholders: No minimum subscription requirement
- Subscription period ends: January 31st, 2025
Business Development
The company continues to make progress in its development of thorium-based technologies, with promising advancements in both extraction capabilities and processing methods. Thorium Norway AS is well-positioned to serve growing markets in both the medical sector and clean energy industry.
Documentation
The following documents are available for review:
- Share Issue Information Document [PDF]
- Board Meeting Presentation [PDF]
- Share Subscription Form [PDF]
- Convertible Loan Subscription Form [PDF]
Information Meetings
Information meetings will be held via Teams between January 20-24th. For more information or to receive subscription documents, please contact:
Contact Information:
- General inquiries: post@thoriumnorway.com
- Albert Aasbø Jr.: +47 934 48 290 / albert@thoriumnorway.com
- Øyvind Holm: +47 911 80 268 / oyvind.holm@thoriumnorway.com